|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's range||250.61 - 255.18|
|52-week range||200.32 - 290.20|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||13.54|
|Earnings date||16 Feb 2023|
|Forward dividend & yield||2.88 (1.13%)|
|Ex-dividend date||22 Feb 2023|
|1y target est||281.00|
ResMed's (RMD) mask sales growth was strong across the globe, reflecting a post-COVID pandemic awareness about the importance and need for respiratory hygiene and respiratory health.
Negative foreign exchange impact and consumables inventory deleveraging are expected to have affected Illumina's (ILMN) top line during the fourth quarter.
CVS Health's (CVS) digital capabilities are expected to have driven consumer engagement across all CVS Health businesses in Q4.